RecruitingNot ApplicableNCT07003906

Treating Emergency Laparotomy Incisions With Negative Pressure Wound Therapy

Sponsor

Uppsala University

Enrollment

720 participants

Start Date

Dec 16, 2025

Study Type

INTERVENTIONAL

Conditions

Quality of Life Surgical Site Infection Incisional Hernia Surgical Incision Wound Dehiscence

Summary

The goal of this clinical trial is to investigate Negative Pressure Wound Therapy (NPWT) in adults undergoing emergency laparotomy. The main question it aims to answer is: Does NPWT decrease wound complications? Researchers will compare it against regular dressings to see if NPWT is superior.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Negative pressure wound therapy and a medical device called Standard postoperative dressing for people with incisional hernia, quality of life, and other related conditions. The study is currently recruiting participants at 6 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENegative pressure wound therapy

Avance Solo Negative Pressure Wound Therapy (NPWT) System is a portable battery powered single use negative pressure system, suitable for use in closed incision and chronic wound indications. The system consists of Avance Solo Pump, Avance Solo Canister 50 mL, Avance Solo Border Dressing and Avance Solo Foam.

DEVICEStandard postoperative dressing

Mepilex Border Post-Op is a self-adhesive absorbent surgical dressing designed for exuding wounds. It is intended for acute wounds, such as surgical wounds, cuts and abrasions.